NZ507349A - Spisulosine Compounds having antitumour activity - Google Patents

Spisulosine Compounds having antitumour activity

Info

Publication number
NZ507349A
NZ507349A NZ507349A NZ50734999A NZ507349A NZ 507349 A NZ507349 A NZ 507349A NZ 507349 A NZ507349 A NZ 507349A NZ 50734999 A NZ50734999 A NZ 50734999A NZ 507349 A NZ507349 A NZ 507349A
Authority
NZ
New Zealand
Prior art keywords
antitumour activity
spisulosine
compounds
spisulosine compounds
hydroxyalkane
Prior art date
Application number
NZ507349A
Inventor
Robert Arthur Warwick
Gravalos Dolores Garcia
Jesus Avila
Glynn Thomas Faircloth
Kenneth Lloyd Rinehart
Nancy Louise Fregeau
Original Assignee
Univ Illinois
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Illinois filed Critical Univ Illinois
Priority claimed from PCT/GB1999/001091 external-priority patent/WO1999052521A1/en
Publication of NZ507349A publication Critical patent/NZ507349A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A pharmaceutical composition containing a long-chain, straight-chain 2-amino-3-hydroxyalkane, together with a pharmaceutically acceptable carrier. In particular the 2-amino-3-hydroxyalkane is C16-C24, especially C18, such as spisulosine 285. The composition is described for the treatment of cancer.
NZ507349A 1998-04-10 1999-04-09 Spisulosine Compounds having antitumour activity NZ507349A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85845698A 1998-04-10 1998-04-10
PCT/GB1999/001091 WO1999052521A1 (en) 1998-04-10 1999-04-09 Spisulosine compounds having antitumour activity

Publications (1)

Publication Number Publication Date
NZ507349A true NZ507349A (en) 2002-12-20

Family

ID=25328353

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ507349A NZ507349A (en) 1998-04-10 1999-04-09 Spisulosine Compounds having antitumour activity

Country Status (1)

Country Link
NZ (1) NZ507349A (en)

Similar Documents

Publication Publication Date Title
EP1193270A3 (en) Pyrrolobenzodiazepines
IL100942A0 (en) 2,4-diaminoquinazoline derivatives for enhancing antitumor activity
ATE312080T1 (en) MEDICINAL PRODUCTS CONTAINING 2-QUINOLONES
IL99906A0 (en) Quinazoline derivatives for enhancing antitumor activity
MY140398A (en) 4-AMINO-6-PHENYL-PYRROLO[2,3-d]PYRIMIDINE DERIVATIVES
MX9602683A (en) 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutically active substances.
HUT67742A (en) Phosphono-oxymethyl-ethers of taxane derivatives
IL137219A0 (en) Potassium channel inhibitors
MY129973A (en) Sulphonylbenzyl-substituted pyridones.
CA2338638A1 (en) Use of l-carnitine and its alkanoyl derivatives in the preparation of medicaments with anticancer activity
NZ334124A (en) Use of the chelating agent clioquinol, with vitamin B12 for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease
ZA9710796B (en) Oxyiminopregnanecarbolactones.
MX9605023A (en) Imidazolidine-2,4-dione substituted compounds, as pharmaceutically active substances.
MY102185A (en) Stabilized human tissue plasminogen activator compositions
UA29466C2 (en) Pharmaceutical composition with antitumour activity
CA2108903A1 (en) Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
ZA922297B (en) Crystalline tiababine monohydrate,its preparation and use
MX9800945A (en) Use of griseofulvin for inhibiting the growth of cancers.
JO1704B1 (en) New active compounds
GB9907571D0 (en) Compounds
NZ507349A (en) Spisulosine Compounds having antitumour activity
WO2001012607A3 (en) Pharmaceutical compositions comprising 4-quinolones for treating cancers
NZ515685A (en) Use of riluzole for the treatment of multiple sclerosis
YU46302A (en) Substituted pyrroles
WO1999056697A3 (en) Pharmaceutical composition

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)